News Feature Channel: Diabetes

Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome

Monell Chemical Senses Center — Thu, 17 Apr 2025 20:45:00 EST

Monell Center investigators identified that GLP-1R agonists, a class of drugs currently used to treat type-2 diabetes and obesity, as a promising therapeutic for managing the metabolic complications associated with Bardet-Biedl Syndrome (BBS), a rare genetic disorder characterized by early-onset obesity, compulsive eating, and cognitive impairments. They used a genetically engineered mouse model of BBS that displayed the hallmark features of the condition.

Studying Interventions to Help Type 2 Diabetes Patients Avoid Hospitalizations

Michigan Medicine - University of Michigan — Tue, 15 Apr 2025 19:30:40 EST

Social determinants of health can have a large impact on the health of people living with type 2 diabetes

More Adults Now Use Tirzepatide and Semaglutide Over Conventional Glucose and Weight Lowering Medications

American College of Physicians (ACP) — Mon, 14 Apr 2025 17:00:00 EST

A population-based cohort study measured trends in use of tirzepatide versus other glucose-lowering medications (GLMs) and weight-lowering medications (WLMs) after tirzepatide's FDA approval.

Neonatal Diabetes Model Provides Insights on How Condition Develops

UT Southwestern Medical Center — Tue, 08 Apr 2025 19:10:06 EST

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes suggests the condition stems from gradual damage to the pancreas through misregulation of a molecular pathway called the unfolded protein response (UPR). The findings, published in Molecular Metabolism, could one day lead to new ways to treat more common subsets of diabetes, including Types 1 and 2, which affect hundreds of millions worldwide.

Einstein Research Leads to Designation of New Type of Diabetes

Albert Einstein College of Medicine — Tue, 08 Apr 2025 15:00:39 EST

Malnutrition-related diabetes--typically affecting lean, malnourished teens and young adults in low- and middle-income countries--is now officially recognized as a distinct form of the disease, known as type 5 diabetes.

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Sbarro Health Research Organization (SHRO) — Mon, 07 Apr 2025 14:45:45 EST

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Switching to Tirzepatide Rather Than Increasing Dulaglutide Dose Leads to Better Glucose Control and More Weight Loss in Patients with Inadequately Controlled Diabetes

American College of Physicians (ACP) — Fri, 04 Apr 2025 10:00:00 EST

For patients with inadequately controlled type 2 diabetes, switching to tirzepatide improves glucose control and increases weight loss more so than maximizing dulaglutide dose.

ACP and Annals of Internal Medicine Present Breaking Scientific ��Ҵ�ý at ACP's Internal Medicine Meeting 2025

American College of Physicians (ACP) — Fri, 04 Apr 2025 10:00:00 EST

Today at the American College of Physicians (ACP) annual meeting, Internal Medicine Meeting 2025, in New Orleans, Annals of Internal Medicine presented three breaking scientific research articles during a live plenary session featuring the authors of those articles.

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

American Physiological Society (APS) — Thu, 03 Apr 2025 07:00:32 EST

Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB's 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society's (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS' flagship annual meeting, will be held April 24-27 in Baltimore.

Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry

Hackensack Meridian Pascack Valley Medical Center — Tue, 01 Apr 2025 09:00:38 EST

We're pleased to announce Carolyn Mudry, D.O, has joined the Pascack Valley Medical Group family. With over 25 years of experience, Dr. Mudry brings a wealth of expertise in providing comprehensive, patient-centered care to the patients of Pascack Valley.

Antibiotics Exposure in Infancy May Boost Diabetes Risk

University of Colorado Boulder — Mon, 31 Mar 2025 17:55:26 EST

Exposure to antibiotics during infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life. The findings shine a light on the importance of the infant microbiome and could lead to new approaches for addressing metabolic diseases.

Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit

American College of Physicians (ACP) — Mon, 31 Mar 2025 17:00:00 EST

Obesity is a leading cause of morbidity and mortality with wide-ranging health consequences that cross-cut many medical specialties.

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

American College of Physicians (ACP) — Mon, 31 Mar 2025 17:00:00 EST

An analysis of nationally representative survey data examined trends in glucagon-like peptide-1 receptor agonist (GLP-1RA) use and expenditure among people in the United States without diabetes.

Endocrine Society Statement on HHS Restructuring, Mass Firings, and Scientific Review

Endocrine Society — Fri, 28 Mar 2025 18:15:20 EST

A major reorganization of the U.S. Department of Health and Human Services (HHS)--including massive cuts to the federal workforce--threatens scientific progress that drives our economy and improves the public's health.

Research Finds Potential "Molecular Mimics" Behind COVID-Induced Autoimmune Disease

University of Utah Health — Wed, 26 Mar 2025 21:00:48 EST

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes. Scientists used advanced data analysis and machine learning to identify viral proteins that are more likely to trigger autoimmunity.

Study Unlocks How Diabetes Distorts Memory and Reward Processing

University of Nevada, Las Vegas (UNLV) — Wed, 26 Mar 2025 20:05:50 EST

Type 2 diabetes may rewire the brain in ways that mimic early Alzheimer's disease -- and UNLV researchers say the "why" may lie in a previously unexplored connection between high blood sugar levels and a key part of the brain called the anterior cingulate cortex (ACC).

Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With Type 1 Diabetes

Johns Hopkins Bloomberg School of Public Health — Wed, 26 Mar 2025 09:40:49 EST

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs' safety and effectiveness in this patient population, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

NUS Researchers Develop Microneedle Technology to Accelerate Diabetic Wound Healing

National University of Singapore (NUS) — Tue, 25 Mar 2025 22:50:51 EST

Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds are marked by persistent inflammation, affecting more than six per cent of the global population. In Singapore, there are about four lower limb amputations daily due to non-healing diabetic wounds. A study focusing on diabetic wounds in Singapore estimated that the gross amputation-related healthcare cost per patient was S$23,000 in 2017.

Improving GLP-1 Drug Delivery by 'Painting' It on Antibodies

American Chemical Society (ACS) — Sun, 23 Mar 2025 05:00:00 EST

Researchers have "painted" GLP-1 receptor agonists onto antibodies through a reaction that happens inside the body. In animal models, a single dose worked better and lasts longer than currently administered dosages. They will present their results at ACS Spring 2025.

Mejora en la administracion del GLP-1 al "pintarlos" en los anticuerpos

American Chemical Society (ACS) — Sun, 23 Mar 2025 05:00:00 EST

Los investigadores han "pintado" los agonistas del receptor del GLP-1 en anticuerpos a traves de una reaccion que se produce dentro del organismo. En modelos animales, una sola dosis actuo mejor y duro mas que las dosis administradas en la actualidad. Presentaran sus resultados en el encuentro de primavera de 2025 de la ACS.

News Feature Channel: Diabetes

Monell Center Study Identifies GLP-1 Therapies as a Possible Treatment for Rare Genetic Disorder Bardet-Biedl Syndrome

Studying Interventions to Help Type 2 Diabetes Patients Avoid Hospitalizations

More Adults Now Use Tirzepatide and Semaglutide Over Conventional Glucose and Weight Lowering Medications

Neonatal Diabetes Model Provides Insights on How Condition Develops

Einstein Research Leads to Designation of New Type of Diabetes

Sbarro Health Research Organization's Professor Antonio Giordano to Attend Innovaway's U.S. Expansion Event in New York City

Switching to Tirzepatide Rather Than Increasing Dulaglutide Dose Leads to Better Glucose Control and More Weight Loss in Patients with Inadequately Controlled Diabetes

ACP and Annals of Internal Medicine Present Breaking Scientific ���Ҵ�ý at ACP's Internal Medicine Meeting 2025

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

Hackensack Meridian Pascack Valley Medical Group Welcomes Dr. Carolyn Mudry

Antibiotics Exposure in Infancy May Boost Diabetes Risk

Unifying Efforts to Empower Equitable Obesity Care: Synopsis of an American College of Physicians and Council of Subspecialty Societies Summit

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

Endocrine Society Statement on HHS Restructuring, Mass Firings, and Scientific Review

Research Finds Potential "Molecular Mimics" Behind COVID-Induced Autoimmune Disease

Study Unlocks How Diabetes Distorts Memory and Reward Processing

Weight-Loss Drug Use Has Risen Sharply Among Children and Adults With Type 1 Diabetes

NUS Researchers Develop Microneedle Technology to Accelerate Diabetic Wound Healing

Improving GLP-1 Drug Delivery by 'Painting' It on Antibodies

Mejora en la administracion del GLP-1 al "pintarlos" en los anticuerpos

ACP and Annals of Internal Medicine Present Breaking Scientific ��Ҵ�ý at ACP's Internal Medicine Meeting 2025